SPRY

Healthcare Biotechnology

ARS Pharmaceuticals, Inc.

$4.07

+0.01 +0.25% today

Price History

Not enough data

Key Stats

Market Cap

404.75M

Avg Volume

1.85M

EPS

-$2.18

52W High

$13.15

52W Low

$3.99

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-4.54

P/B Ratio

32.30

P/S Ratio

3.46

EV/EBITDA

-2.02

EV/Revenue

3.70

Margins

Gross Margin 58.3%

Operating Margin (182.6%)

Net Margin (184.2%)

EBITDA Margin (183.6%)

Growth & Returns

Revenue Growth (YoY)

114.2%

Return on Equity

(210.3%)

Return on Assets

(48.0%)

Liquidity & Leverage

Current Ratio

3.48

Quick Ratio

3.15

Debt / Equity

13.72

Total Cash

143.84M

Total Debt

171.60M

About

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

ars-pharma.com